Connect your AI

Haemonetics HAE Other Income (Expense)

Other Income (Expense) at other companies

TFX

TeleflexTFX

27.1%+25.5pp

MedtronicMDT

$137M—

LivaNovaLIVN

-$5.7M-150%

ICU MedicalICUI

-$1.06M+39.9%

Merit Medical SystemsMMSI

$9.39M+405%

DanaherDHR

-$73M+7.6%

Other financials

Income statement

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

Market cap$3.31B-18.0%

Profitability

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Haemonetics's other income (expense)?: Haemonetics (HAE) reported other income (expense) of -$5.37M in Q1 2026.
How has Haemonetics's other income (expense) changed year-over-year?: Haemonetics's other income (expense) decreased by 798.7% year-over-year, from -$598K to -$5.37M.
What is the long-term trend for Haemonetics's other income (expense)?: Over 4 years (2022 to 2026), Haemonetics's other income (expense) has grown at a 13.8% compound annual growth rate (CAGR), from -$17.12M to -$28.7M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.